Related Experiment Video
Updated: Feb 12, 2026

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
Published on: October 7, 2017
Safety of propofol sedation directed by endoscopists: how long should we continue to generate evidence?
José Carlos Marín-Gabriel1, Pilar Martínez-Montiel1
1Servicio de Medicina de Aparato Digestivo, Hospital Universitario 12 de Octubre, España.
Abstract:
The administration of propofol by endoscopists is a source of permanent friction with the Societies of Anesthesiology, which is based more on a clear conflict of economic interest on the part of the anesthesiologists than supported by scientific evidence. Maestro Antolín et al. (1) presented a series of more than 33,000 sedations performed with propofol by endoscopists, observing a frequency of cardiorespiratory adverse events of 0.13%. Rather than confrontation between different specialties, where the corporatism of the Anesthesiology Societies and their interest in monopolizing the use of a safe drug such as propofol prevails with no scientific support, anesthesiologists, endoscopists and nurses should instead work together for the benefit of our patients.
Insights
Endoscopists can safely administer propofol, with a low 0.13% adverse event rate in over 33,000 sedations. This challenges anesthesiologists' claims and supports collaborative patient care.
Area of Science:
- Gastroenterology
- Anesthesiology
- Medical Economics
Background:
- Ongoing conflict exists between endoscopists and anesthesiology societies regarding propofol administration.
- This friction appears driven by economic interests rather than scientific evidence.
Purpose of the Study:
- To evaluate the safety and efficacy of propofol administration by endoscopists.
- To provide evidence to address the conflict between medical specialties regarding sedation practices.
Main Methods:
- Analysis of a large cohort of over 33,000 sedation procedures.
- Data collection on cardiorespiratory adverse events during propofol-induced sedation by endoscopists.
Main Results:
- A low frequency of 0.13% for cardiorespiratory adverse events was observed.
- The study demonstrates a high safety profile for propofol when administered by trained endoscopists.
Conclusions:
- Propofol sedation administered by endoscopists is associated with a low rate of adverse events.
- Collaboration between anesthesiologists, endoscopists, and nurses is recommended for optimal patient outcomes, moving beyond inter-specialty conflicts.
Related Concept Videos
The Evidence for Evolution
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Survey Safety
Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

